NIPRONorthern Illinois Proteges
References in periodicals archive ?
TC BioPharm Ltd and the NIPRO Corporation (TYO: 8086) have formed a strategic collaboration to co-develop a new type of cancer therapy, the private Scottish company announced on Wednesday.
Key players covered include GlaxoSmithKline plc, Boehringer Ingelheim GmbH, AstraZeneca PLC, Terumo Corporation, Sunovion, NIPRO CORPORATION and others.